
About Rexcin Pharmaceuticals
Rexcin Pharmaceuticals is a Healthcare company based in Delhi (India) founded in 2003. It manufactures and markets dermatological pharmaceutical products. It operates on a B2B model. The company has 1 employees. Its Indian entity Rexcin Pharmaceuticals Private Limited reported revenue of βΉ8.57 Cr. Its focus areas include Pharmaceuticals, Dermatology and Product Manufacturing and Marketing. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.
Company details
Rexcin Pharmaceuticals manufactures and markets dermatological pharmaceutical products through providing healthcare solutions, producing pharmaceutical products, dermatology, and product manufacturing and marketing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Delhi, India
- Employees 1
- SectorsHealthcare
- Website rexcinpharma.com
- Legal Name Rexcin Pharmaceuticals Private Limited
- Date of Incorporation 16 Dec, 2003
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹8.57 Cr
FY 2025 · +15% YoY
- Net Profit₹2.05 Cr
FY 2025 · 24% margin
- EBITDA₹2.81 Cr
FY 2025 · 33% margin
- Employee Count1
Associated legal entities of Rexcin Pharmaceuticals
Rexcin Pharmaceuticals operates through Rexcin Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rexcin Pharmaceuticals Private Limited CIN U24239DL2003PTC123544 | Active | 16 Dec 2003 | New Delhi, Delhi | ₹8.6 Cr | 1 | 2 | View details |
Board of directors of Rexcin Pharmaceuticals Private Limited (Rexcin Pharmaceuticals)
Rexcin Pharmaceuticals Private Limited is the primary company behind Rexcin Pharmaceuticals. The board of Rexcin Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Pradeep Saxena, appointed in 2013. 15 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pradeep Saxena DIN 03535793 | Director | 31 Jul 2013 | 13 yrs 3 mo | Rexcin Pharmaceuticals Private Limited |
| Satinder Pal Singh DIN 02676056 | Director | 15 Jul 2015 | 11 yrs 4 mo | Rexcin Pharmaceuticals Private Limited |
Financials of Rexcin Pharmaceuticals
Figures of Rexcin Pharmaceuticals Private Limited, the primary company behind Rexcin Pharmaceuticals, for FY 2025. Revenue was ₹8.57 Cr (+15% year on year). Net profit was ₹2.05 Cr (24% margin). EBITDA was ₹2.81 Cr (33% margin). Revenue has grown at a compounded annual rate of -3% over three years and -8% over five years.
- ₹8.57 CrRevenue · FY 2025 · +15% YoY
- ₹2.05 CrNet profit · 24% margin
- ₹2.81 CrEBITDA · 33% margin
- ₹2 LakhPaid-up capital
- 1Employees (provident fund records)
- -3%Revenue CAGR, 3 years
- -8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Rexcin Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Rexcin Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Rexcin Pharmaceuticals
Rexcin Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed similar companies of Rexcin Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rexcin Pharmaceuticals
Rexcin Pharmaceuticals was founded in 2003.
Rexcin Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Rexcin Pharmaceuticals has 1 employees.
The primary company behind Rexcin Pharmaceuticals, Rexcin Pharmaceuticals Private Limited, reported revenue of βΉ8.57 Cr for FY 2025, up 15% year on year.
Rexcin Pharmaceuticals manufactures and markets dermatological pharmaceutical products through providing healthcare solutions, producing pharmaceutical products, dermatology, and product manufacturing and marketing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Rexcin Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Rexcin Pharmaceuticals operates through Rexcin Pharmaceuticals Private Limited.
The legal entities of Rexcin Pharmaceuticals currently have 2 directors, including Satinder Pal Singh, Pradeep Saxena.